| Literature DB >> 33194822 |
Julia Monjarás Feria1, Miguel A Valvano1.
Abstract
The type VI secretion system (T6SS) is a transmembrane multiprotein nanomachine employed by many Gram-negative bacterial species to translocate, in a contact-dependent manner, effector proteins into adjacent prokaryotic or eukaryotic cells. Typically, the T6SS gene cluster encodes at least 13 conserved core components for the apparatus assembly and other less conserved accessory proteins and effectors. It functions as a contractile tail machine comprising a TssB/C sheath and an expelled puncturing device consisting of an Hcp tube topped by a spike complex of VgrG and PAAR proteins. Contraction of the sheath propels the tube out of the bacterial cell into a target cell and leads to the injection of toxic proteins. Different bacteria use the T6SS for specific roles according to the niche and versatility of the organism. Effectors are present both as cargo (by non-covalent interactions with one of the core components) or specialized domains (fused to structural components). Although several anti-prokaryotic effectors T6SSs have been studied, recent studies have led to a substantial increase in the number of characterized anti-eukaryotic effectors. Against eukaryotic cells, the T6SS is involved in modifying and manipulating diverse cellular processes that allows bacteria to colonize, survive and disseminate, including adhesion modification, stimulating internalization, cytoskeletal rearrangements and evasion of host innate immune responses.Entities:
Keywords: T6SS; bacterial pathogenesis; effector; host manipulation; secretion system
Year: 2020 PMID: 33194822 PMCID: PMC7641602 DOI: 10.3389/fcimb.2020.584751
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
List of anti-eukaryotic T6SS effectors and their functions.
| Contains an actin cross-linking domain (ACD) that binds and covalently cross-links actin, leading to an accumulation of toxic actin oligomers and altering host cell morphology, preventing host cell cytoskeletal rearrangements and disabling phagocytosis. | Pukatzki et al., | ||
| Required for virulence toward | Miyata et al., | ||
| Predicted MIX-effector with a C-terminal domain homologous to cytotoxic proteins and other T6SS effectors that contain Rhs repeats. | Ray et al., | ||
| MIX V effector containing a CNF1 domain that targets Rho GTPases resulting in actin cytoskeleton rearrangements in macrophages and toxicity to yeast. | Ray et al., | ||
| Predicted effector homologous to the C-terminal domain of the insecticidal toxin Txp40 of | Ray et al., | ||
| Enterohemorrhagic | Mn2+-containing catalase secreted into the host cell's cytosol after phagocytosis. It decreases the level of intracellular reactive oxygen species, enabling bacterial survival in macrophages. | Wan et al., | |
| Extra-intestinal pathogenic | Involved in bacterial adherence, multiplication, and evasion of innate immune responses. | Zong et al., | |
| Phospholipase D effector; it induces PI3K activation by interacting with Akt1 and Akt2 and promotes bacterial internalization into non-phagocytic cells. | Wilderman et al., | ||
| Phospholipase D effector; it promotes bacterial internalization into epithelial cells | Bleves et al., | ||
| Enables entry into non-phagocytic cells by interacting with members of the microtubule γ-TuRC complex. | Sana et al., | ||
| Contains a eukaryotic PGAP1-like domain, which targets the host cell's ER leading to an unfolded protein response through the IRE1α-XBP1 pathway, which in turns induces stress and autophagy. | Jiang et al., | ||
| Essential phospholipase for bacterial virulence in mice that plays a role in pathogenesis. It is encoded within a T6SS core gene cluster. | Lery et al., | ||
| Plays a role in T6SS-mediated intoxication of fungal cells. | Storey et al., | ||
| Plays a role in phagosomal escape, trafficking to lysosomes, intramacrophage replication and is important for virulence | Lindgren et al., | ||
| Contributes to intramacrophage growth and phagosomal rupture. It is required to activate the AIM2 inflammasome. | Ludu et al., | ||
| Contributes to intramacrophage bacterial growth by promoting bacterial endosomal escape into the cytoplasm. It belongs to a family of bacterial PI3K enzymes and also plays a role in evasion of innate immunity in host cells by reducing the levels of TNF-α. | Eshraghi et al., | ||
| Contributes to intracellular growth in phagocytic cells. The C-terminus is homologous to the ankyrin repeat domains and the N-terminus corresponds to an evolutionarily conserved cysteine protease. | Eshraghi et al., | ||
| It is translocated into macrophages and associates to microtubule organizing centers modulating membrane trafficking for bacterial intracellular growth. | Broms et al., | ||
| The C-terminal domain interacts with EvpC and suppresses activation of the NLRP3 inflammasome by inhibiting the Ca2+-dependent MAPK-Jnk pathway. NLRP3 inhibition promotes bacterial colonization. | Zheng and Leung, | ||
| Plays a role in host cell colonization, apoptosis and necrosis in macrophages. Promotes adhesion and internalization. | Kalindamar et al., | ||
| EvpP-inhibits the Jnk-MAPK pathway and Jnk-caspy inflammasome signaling pathways suppressing recruitment of neutrophils to infection sites and promoting bacterial colonization. Interacts with ribosomal protein S5 (RPS5) to regulate apoptosis. | Tan et al., | ||
| Disrupts macrophage actin cytoskeleton by deamidating Rho GTPases, which results in the activation of the Pyrin inflammasome. | Aubert et al., | ||
| The C-terminal domain is involved in mediating multinucleated giant cell formation, membrane fusion and virulence in mice. | Schwarz et al., | ||
| Acts against fungal cells causing plasma membrane depolarization leading to cell death. | Trunk et al., | ||
| Acts against target fungal cells, leading to fungal cell death. Disrupts nutrient uptake and amino acid metabolism leading to the induction of autophagy. | Trunk et al., | ||
| Targets the actin cytoskeleton. Has a vegetative insecticidal protein-2 domain with actin ADP-ribosyl transferase activity. | Suarez et al., | ||
| Zn2+-binding effector that protects the pathogen from ROS and plays a role in virulence. | Wang et al., | ||
Figure 1Schematic illustration of current models for the role of some anti-eukaryotic effectors. (A) P. aeruginosa delivers PldA and PldB which bind Akt to allow bacterial internalization via the induction of the PI3K pathway. VgrG2b enables bacterial internalization by interacting with members of the microtubule γ-TuRC complex. TplE targets the endoplasmic reticulum (ER) and induces stress and autophagy. (B) B. cenocepacia TecA is a deamidase that disrupts actin cytoskeleton by deamidating Rho GTPases and activates the Pyrin inflammasome. (C) The V. cholerae evolved VgrG1 interacts with and cross-link actin, leading to an accumulation of toxic actin oligomers and altering host cell morphology. VasX binds the lipid membrane phosphatidic acid (PA) and is thought to form pores in lipid bilayers. V. proteolyticus Vpr01570 contains a deamidase domain that activates Rho GTPases. (D) F. tularensis OpiA is a kinase able to phosphorylate phosphatidylinositol (PI) and binding to phosphatidylinositol trisphosphate [PI(3)P] for its recruitment to endosomal membranes. PdpC and PdpD activate AIM2 inflammasome. (E) E. tarda translocates EvpP which modifies calcium flux and has an inhibitory role in NLRP3 inflammasome by reducing Jnk phosphorylation and ASC oligomerization. E. ictalurid EvpP interacts with ribosomal protein S5 to negatively regulate apoptosis. (F) The EHEC effector KatN is a catalase that contributes to the survival in macrophages by hydrolyzing and decreasing the levels of reactive oxygen species (ROS). VgrG1 is secreted by ExPEC that alters the IL-1β levels. This figure was prepared using free templates on the Servier medical art website (https://smart.servier.com/).
| ABM | actin binding motif |
| ACD | actin cross-linking domain |
| CNF1 | cytotoxic necrotizing factor 1 |
| EHEC | enterohemorrhagic |
| ER | endoplasmic reticulum |
| ExPEC | extra-intestinal pathogenic |
| FPI | Francisella pathogenicity island |
| MIX | marker for type six effectors |
| PA | phosphatidic acid |
| PH | Pleckstrin-homology |
| PI | phosphatidylinositol |
| PI(3)P | phosphatidylinositol 3-phosphate |
| PI3K | phosphatidylinositol 3-kinase |
| PIP | phosphatidylinositol phosphates |
| PIP3 | phosphatidylinositol-3,4,5-triphosphate |
| PLD | phospholipase D |
| ROS | reactive oxygen species |
| γ-TuRC | gamma-tubulin ring complex |